Mechanisms of endocrine disruptions a tentative overview

Endocrine Disruption Modeling

Volumn , Issue , 2009, Pages 11-46

  Porcher, Jean Marc ^a   Devillers, James ^b   Marchand Geneste, Nathalie ^c  

^a INSTITUT NATIONAL DE L ENVIRONNEMENT INDUSTRIEL ET DES RISQUES INERIS   (France)

^b Centre de Traitement de l Information Scientifique (CTIS)   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Endocrine disrupting chemicals (EDCs); Interactions; Mechanisms; Nuclear receptors; Steroidogenesis

Indexed keywords

EID: 84947129955     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420076363     Document Type: Chapter

References (207)

1. IPCS, Global assessment of the state-of-the-science of endocrine disruptors, in International Program on Chemical Safety, IPCS, 2002, pp. 180.
2. J.M. Olefsky, Nuclear receptor minireview series, J. Biol. Chem. 276 (2001), pp. 36863-36864.
3. P. Germain, B. Staels, C. Dacquet, M. Spedding, and V. Laudet, Overview of nomenclature of nuclear receptors, Pharmacol. Rev. 58 (2006), pp. 685-704.
4. D.J. Mangelsdorf, C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, M. Kastner, M. Mark, P. Chambon, and R.M. Evans, The nuclear receptor superfamily: The second decade, Cell 83 (1995), pp. 835-839.
5. N. Novac and T. Heinzel, Nuclear receptors: Overview and classification, Curr. Drug Targets Inflamm. Allergy 3 (2004), pp. 335-346.
6. V. Laudet, Evolution of the nuclear receptor superfamily: Early diversification from an ancestral orphan receptor, J. Mol. Endoc. 19 (1997), pp. 207-226.
7. Nuclear Receptor Nomenclature Committee, A unified nomenclature system for the nuclear receptor superfamily, Cell 97 (1999), pp. 161-163.
8. M. Robinson-Rechavi, H. Escriva Garcia, and V. Laudet, The nuclear receptor superfamily, J. Cell Sci. 116 (2003), pp. 585-586.
9. J.M. Maglich, J.A. Caravella, M.H. Lambert, T.M. Willson, J.T. Moore, and L. Ramamurthy, The first completed genome sequence from a teleost fish (Fugu rubipes) adds significant diversity to the nuclear receptor superfamily, Nucleic Acids Res. 31 (2003), pp. 4051-4058.
10. A.N. Smirnov, Nuclear receptors: Nomenclature, ligands, mechanisms of their effects on gene expression, Biochem. (Moscow) 67 (2002), pp. 957-977.
11. B.S. Katzenellenbogen and J.A. Katzenellenbogen, Defining the “S” in SERMs, Science 295 (2002), pp. 2380-2381.
12. J.A. Katzenellenbogen and R. Muthyala, Interactions of exogenous endocrine active substances with nuclear receptors, Pure Appl. Chem. 75 (2003), pp. 1797-1817.
13. C.A. Smith and B.W. O’Malley, Coregulator function: A key to understanding tissue specificity of selective receptor modulators, Endocrinol. Rev. 25 (2004), pp. 45-71.
14. J.M. Hall and D.P. McDonnell, The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens, Endocrinology 140 (1999), pp. 5566-5578.
15. G. Pascual and C.K. Glass, Nuclear receptors versus inflammation: Mechanisms of transrepression, Trends Endocrinol. Metab. 17 (2006), pp. 321-327.
16. L. Björnström and M. Sjöberg, Estrogen receptor-dependent activation of AP-1 via non-genomic signalling, Nucl. Recept. 2 (2004), pp. 3.
17. R.M. Lösel, E. Falkenstein, M. Feuring, A. Schultz, H.C. Tillmann, K. Rossol-Haseroth, and M. Wehling, Nongenomic steroid action: Controversies, questions, and answers, Physiol. Rev. 83 (2003), pp. 965-1016.
18. D. Zivadinovic, B. Gametchu, and C.S. Watson, Membrane estrogen receptor-α levels in MCF-7 breast cancer cells predict cAMP and proliferation responses, Breast Cancer Res. 7 (2005), pp. 101-112.
19. F. Acconcia and R. Kumar, Signaling regulation of genomic and nongenomic functions of estrogen receptors, Cancer Lett. 238 (2006), pp. 1-14.
20. L.A. Paige, D.J. Christensen, H. Grøn, J.D. Norris, E.B. Gottlin, K.M. Padilla, C.-Y. Chang, L.M. Ballas, P.T. Hamilton, D.P. McDonnell, and D.M. Fowlkes, Estrogen receptor (ER) modulators each induce distinct conformational changes in ERα and ERβ, Proc. Natl. Acad. Sci. USA 96 (1999), pp. 3999-4004.
21. P.J. Kushner, P. Webb, R.M. Uht, M.M. Liu, and R.H. Price, Estrogen receptor action through target genes with classical and alternative response elements, Pure Appl. Chem. 75 (2003), pp. 1757-1769.
22. K. Pettersson, F. Delaunay, and J.A. Gustafsson, Estrogen receptor β acts as a dominant regulator of estrogen signaling, Oncogene 19 (2000), pp. 4970-4978.
23. M.B. Hawkins, J.W. Thornton, D. Crews, J.K. Skipper, A. Dotte, and P. Thomas, Identification of a third distinct estrogen receptor and reclassification of estrogen receptors in teleosts, Proc. Natl. Acad. Sci. USA 97 (2000), pp. 10751-10756.
24. J.P. Sumpter, Xenoendocrine disrupters — Environmental impacts, Toxicol. Lett. 102-103 (1998), pp. 337-342.
25. M. Marino, P. Galluzzo, and P. Ascenzi, Estrogen signaling multiple pathways to impact gene transcription, Curr. Genomics 7 (2006), pp. 497-508.
26. S.O. Mueller, Xenoestrogens: Mechanisms of action and detection methods, Anal. Bioanal. Chem. 378 (2004), pp. 582-587.
27. D.M. Lonard and B.W. O’Malley, Expanding functional diversity of the coactivators, Trends Biochem. Sci. 30 (2005), pp. 126-132.
28. H.V. Heemers and D.J. Tindall, Androgen receptor (AR) coregulators: A diversity of functions converging on and regulating the AR transcriptional complex, Endocrinol. Rev. 28 (2007), pp. 778-808.
29. F. Rahman and H.C. Christian, Non-classical actions of testosterone: An update, Trends Endocrinol. Metab. 18 (2007), pp. 371-378.
30. C.A. Quigley, A. De Bellis, K.B. Marschke, M.K. El-Awady, E.M. Wilson, and F.S. French, Androgen receptor defects: Historical, clinical, and molecular perspectives, Endocrinol. Rev. 16 (1995), pp. 271-321.
31. T.S. Sperry and P. Thomas, Characterization of two nuclear androgen receptors in Atlantic croaker: Comparison of their biochemical properties and binding specificities, Endocrinology 140 (1999), pp. 1602-1611.
32. W.R. Kelce, E. Monosson, M.P. Gamcsik, S.C. Laws, and L.E. Gray, Environmental hormone disruptors: Evidence that vinclozoline developmental toxicity is mediated by antiandrogenic metabolites, Toxicol. Appl. Pharmacol. 126 (1994), pp. 275-285.
33. W.R. Kelce and E.M. Wilson, Environmental antiandrogens: Developmental effects, molecular mechanisms, and clinical implications, J. Mol. Med. 75 (1997), pp. 198-207.
34. W.R. Kelce, C.R. Stone, S.C. Laws, L.E. Gray, J.A. Kemppainen, and E.M. Wilson, Persistent DDT metabolite p, p′-DDE is a potent androgen receptor antagonist, Nature 375 (1995), pp. 581-585.
35. K.W. Gaido, L.S. Leonard, S.C. Maness, J.M. Hall, D.P. McDonnell, B. Saville, and S. Safe, Differential interaction of the methoxychlor metabolite 2,2-bis-(p-hydroxyphenyl)-1,1,1trichlorethane with estrogen receptors α and β, Endocrinology 140 (1999), pp. 5746-5753.
36. S.C. Maness, D.P. McDonnell, and K.W. Gaido, Inhibition of androgen receptor-dependent transcriptional activity by DDT isomers and methoxychlor in HepG2 human hepatoma cells, Toxicol. Appl. Pharmacol. 151 (1998), pp. 135-142.
37. H. Tamura, S.C. Maness, K. Reischmann, D.C. Dorman, L.E. Gray, and K.W. Gaido, Androgen receptor antagonism by the organophosphate insecticide fenitrothion, Toxicol. Sci. 60 (2001), pp. 56-62.
38. J. Ostby, W.R. Kelce, C. Lambright, C.J. Wolf, P. Mann, and L.E. Gray, The fungicide procymidone alters sexual differentiation in the male rat by acting as an androgenreceptor antagonist in vivo and in vitro, Toxicol. Ind. Health 15 (1999), pp. 80-93.
39. C. Lambright, J. Ostby, K. Bobseine, V. Wilson, A.K. Hotchkiss, P.C. Mann, and L.E. Gray, Cellular and molecular mechanisms of action of linuron: An antiandrogenic herbicide that produces reproductive malformations in male rats, Toxicol. Sci. 56 (2000), pp. 389-399.
40. B.S. McIntyre, N.J. Barlow, D.G. Wallace, S.C. Maness, K.W. Gaido, and P.M.D. Foster, Effect of in utero exposure of linuron on androgen-dependent reproductive development in male Crl:CD(SD)BR rat, Toxicol. Appl. Pharmacol. 167 (2000), pp. 87-99.
41. I. Katsiadaki, S. Morris, C. Squires, M.R. Hurst, J.D. James, and A.P. Scott, Use of the three-spined stickleback (Gasterosteus aculeatus) as a sensitive in vivo test for detection of environmental antiandrogens, Environ. Health Perspect. 114 (2006), pp. 115-121.
42. I.H. Kang, H.S. Kim, J.H. Shin, T.S. Kim, H.J. Moon, I.Y. Kim, K.S. Choi, K.S. Kil, Y.I. Park, M.S. Dong, and S.Y. Han, Comparison of anti-androgenic activity of flutamide, vinclozolin, procymidone, linuron, and p, p′-DDE in rodent 10-day Hershberger assay, Toxicology 199 (2004), pp. 145-159.
43. G.T. Ankley and J.P. Giesy, Endocrine disruptors in wildlife: A weight of evidence perspective, in Principles and Processes for Assessing Endocrine Disruption in Wildlife, R. Kendall, R. Dickerson, W. Suk, and J.P. Giesy, eds., SETAC Press, Pensacola, Florida, 1998, pp. 349-368.
44. M.M. Gagnon, D. Bussieres, J.J. Dodson, and P.V. Hodson, White sucker (Catostomus commersoni) growth and sexual maturation in pulp mill contaminated and reference rivers, Environ. Toxicol. Chem. 14 (1995), pp. 317-327.
45. L.M. Hewitt, J.L. Parrott, and M.E. McMaster, A decade of research on the environmental impacts of pulp and paper mill effluents in Canada: Sources and characteristics of bioactive substances, J. Toxicol. Environ. Health Part B: Crit. Rev. 9 (2006), pp. 341-356.
46. K.R. Munkittrick, M.E. McMaster, L.H. McCarthy, M.R. Servos, and G.J. Van der Kraak, An overview of recent studies on the potential of pulp-mill effluents to alter reproductive parameters in fish, Toxicol. Environ. Health Part B Crit. Rev. 1 (1998), pp. 347-371.
47. K.R. Munkittrick, C.B. Portt, G.J. Van der Kraak, I.R. Smith, and D.A. Rokosh, Impact of bleached kraft mill effluent on population characteristics, liver MFO activity, and serum steroid levels of a Lake Superior white sucker (Catastomus commersoni) population, Can. J. Fish. Aquat. Sci. 48 (1991), pp. 1371-1380.
48. E. Neuman and P. Karas, Effects of pulp mill effluent on a Baltic coastal fish community, Water Sci. Technol. 20 (1988), pp. 95-106.
49. G. Van der Kraak, T. Zacharewski, D.M. Janz, M.B. Sanders, and J.W. Gooch, Comparative endocrinology and mechanisms of endocrine modulation in fish and wildlife, in Principles and Processes for Evaluating Endocrine Disruption in Wildlife, R. Kendall, R. Dickerson, J.P. Giesy, and W.P. Suk, eds., SETAC Press, Pensacola, 1998, pp. 97-119.
50. R. Jenkins, R.A. Angus, H. McNatt, W.M. Howell, J.A. Kemppainen, M. Kirk, and E.M. Wilson, Identification of androstenedione in a river containing paper mill effluent, Environ. Toxicol. Chem. 20 (2001), pp. 1325-1331.
51. L. Parks, C. Lambright, E. Orlando, L. Guillette, G.T. Ankley, and L.E. Gray, Masculinization of female mosquitofish in kraft mill effluent-contaminated Fenholloway river water is associated with androgen receptor agonist activity, Toxicol. Sci. 62 (2001), pp. 257-267.
52. V.S. Wilson, C. Lambright, J. Ostby, and L.E. Gray, In vitro and in vivo effects of 17 beta trenbolone: A feedlot effluent contaminant, Toxicol. Sci. 70 (2002), pp. 202-211.
53. J.G. Chen, K.C. Ahn, N.A. Gee, M.I. Ahmed, A.J. Duleba, L. Zhao, S.J. Gee, B.D. Hammock, and B.L. Lasley, Triclocarban enhances testosterone action: A new type of endocrine disruptor? Endocrinology 149 (2008), pp. 1173-1179.
54. OECD, Detailed revue paper on thyroid hormone disruption assays, in OECD Series on Testing and Assessment, 2006, pp. 1-434.
55. C.B. Harvey and G.R. Williams, Mechanism of thyroid hormone action, Thyroid 12 (2002), pp. 441-446.
56. S.B. Brown, R.E. Evans, L. Vandenbyllardt, K.W. Finnson, V.P. Palace, A.S. Kane, A.Y. Yarechewski, and D.C.G. Muir, Altered thyroid status in lake trout (Salvelinus namaycush) exposed to co-planar 3,3′,4,4′,5-pentachlorobiphenyl, Aquat. Toxicol. 67 (2004), pp. 75-85.
57. M.S. Christian and N.A. Trenton, Evaluation of thyroid function in neonatal and adult rats: The neglected endocrine mode of action, Pure Appl. Chem. 75 (2003), pp. 2055-2068.
58. M. Kaneko, R. Okada, K. Yamamoto, M. Nakamura, G. Mosconi, A.M. Polzonetti-Magni, and S. Kikuyama, Bisphenol A acts differently from and independently of thyroid hormone in suppressing thyrotropin release from the bullfrog pituitary, Gen. Comp. Endocrinol. 155 (2008), pp. 574-580.
59. Y. Kudo, K. Yamauchi, H. Fukazawa, and Y. Terao, In vitro and in vivo analysis of the thyroid system-disrupting activities of brominated phenolic and phenol compounds in Xenopus laevis, Toxicol. Sci. 92 (2006), pp. 87-95.
60. V.M. Richardson, D.F. Staskal, D.G. Ross, J.J. Diliberto, M.J. DeVito, and L.S. Birnbaum, Possible mechanisms of thyroid hormone disruption in mice by BDE 47, a major polybrominated diphenyl ether congener, Toxicol. Appl. Pharmacol. 226 (2008), pp. 244-250.
61. L.H. Tseng, M.H. Li, S.S. Tsai, C.W. Lee, M.H. Pan, W.J. Yao, and P.C. Hsu, Developmental exposure to decabromodiphenyl ether (PBDE 209): Effects on thyroid hormone and hepatic enzyme activity in male mouse offspring, Chemosphere 70 (2008), pp. 640-647.
62. F. Grün, H. Watanabe, Z. Zamanian, L. Maeda, K. Arima, R. Cubacha, D.M. Gardiner, J. Kanno, T. Iguchi, and B. Blumberg, Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates, Mol. Endocrinol. 20 (2006), pp. 2141-2155.
63. T. Kanayama, N. Kobayashi, S. Mamiya, T. Nakanishi, and J. Nishikawa, Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor g /retinoid X receptor pathway, Mol. Pharmacol. 67 (2005), pp. 766-774.
64. X.C. Kretschmer and W.S. Baldwin, CAR and PXR: Xenosensors of endocrine disrupters? Chem. Biol. Interact. 155 (2005), pp. 111-128.
65. B. Goodwin, M.R. Redinbo, and S.A. Kliewer, Regulation of CYP3a gene transcription by the pregnane X receptor, Annu. Rev. Pharmacol. Toxicol. 42 (2002), pp. 1-23.
66. J. Zhou, J. Zhang, and W. Xie, Xenobiotic nuclear receptor-mediated regulation of UDP-glucuronosyl-transferases, Curr. Drug Metab. 6 (2005), pp. 289-298.
67. C. Xu, C.Y. Li, and A.N. Kong, Induction of phase I, II and III drug metabolism/transport by xenobiotics, Arch. Pharm. Res. 28 (2005), pp. 249-268.
68. L. Michalik, J. Auwerx, J.P. Berger, V. Krishna Chatterjee, C.K. Glass, F.J. Gonzales, P.A. Grimaldi, T. Kadowaki, M.A. Lazar, S. O’Rahilly, C.N.A. Palmer, J. Plutzky, J.K. Reddy, B.M. Spiegelman, B. Staels, and W. Wahli, International union of pharmacology. LXI. Peroxisome proliferator-activated receptors, Pharmacol. Rev. 58 (2006), pp. 726-741.
69. H. Keller, C. Dreyer, J. Medin, A. Mahfoudi, K. Ozato, and W. Wahli, Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferatoractivated receptor-retinoid X receptor heterodimers, Proc. Natl. Acad. Sci. USA 90 (1993), pp. 2160-2164.
70. S.A. Kliewer, K. Umesono, D.J. Noonan, R.A. Heyman, and R.M. Evans, Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors, Nature 358 (1992), pp. 771-774.
71. S. Mandard, M. Muller, and S. Kersten, Peroxisome proliferator-activated receptor a target genes, Cell. Mol. Life Sci. 61 (2004), pp. 393-416.
72. P. Lefebvre, G. Chinetti, J.C. Fruchart, and B. Staels, Sorting out the roles of PPAR a in energy metabolism and vascular homeostasis, J. Clin. Invest. 116 (2006), pp. 571-580.
73. Y. Barak, D. Liao, W. He, E.S. Ong, M.C. Nelson, J.M. Olefsky, R. Boland, and R.M. Evans, Effects of peroxisome proliferator-activated receptor delta on placentation, adiposis, and colorectal cancer, Proc. Natl. Acad. Sci. USA 99 (2002), pp. 303-309.
74. K. Nadra, S.I. Anghel, E. Joye, N.S. Tan, S. Basu-Modak, D. Trono, W. Wahli, and B. Desvergne, Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor β/δ, Mol. Cell. Biol. 26 (2006), pp. 3266-3281.
75. J.M. Peters, S.S. Lee, W. Li, J.M. Ward, O. Gavrilova, C. Everett, M.L. Reitman, L.D. Hudson, and F.J. Gonzales, Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta (delta), Mol. Cell. Biol. 20 (2000), pp. 5119-5128.
76. F. Varnat, B. Bordier-ten Heggeler, P. Grisel, N. Bouquard, I. Corthesy-Theulaz, W. Wahli, and B. Desvergne, PPAR β/δ regulates Paneth cells differentiation via controling the Hedgedhog signaling pathway, Gastroenterology 131 (2006), pp. 538-553.
77. Y.X. Wang, C.H. Lee, S. Tiep, R.T. Yu, J. Ham, H. Kang, and R.M. Evans, Peroxisomeproliferator-activated receptor δ activates fat metabolism to prevent obesity, Cell 113 (2003), pp. 159-170.
78. N. Di-Poi, N.S. Tan, L. Michalik, W. Wahli, and B. Desvergne, Antiapoptotic role of PPARβ in keratinocytes via transcriptional control of the Akt1 signaling pathway, Mol. Cell 10 (2002), pp. 721-733.
79. E. Letavernier, J. Perez, E. Joye, A. Bellocq, B. Fouqueray, J.P. Haymann, D. Heudes, W. Wahli, B. Desvergne, and L. Baud, Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure, J. Am. Soc. Nephrol. 16 (2005), pp. 2395-2402.
80. L. Michalik and W. Wahli, Involvment of PPAR nuclear receptors in tissue injury and wound repair, J. Clin. Invest. 116 (2006), pp. 598-606.
81. N.S. Tan, L. Michalik, N. Noy, R. Yasmin, C. Pacot, M. Heim, B. Flühmann, B. Desvergne, and W. Wahli, Critical roles of PPAR beta/delta in keratinocyte response to inflammation, Genes Dev. 15 (2001), pp. 3263-3277.
82. W.M. He, Y. Barak, A. Hevener, P. Olson, D. Liao, J. Le, M. Nelson, E. Ong, J.M. Olefsky, and R.M. Evans, Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle, Proc. Natl. Acad. Sci. USA 100 (2003), pp. 15712-15717.
83. H. Koutnikova, T.A. Cock, M. Watanabe, S.M. Houten, M.F. Champy, A. Dierich, and J. Auwerx, Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR γ hypomorphic mice, Proc. Natl. Acad. Sci. USA 100 (2003), pp. 14457-14462.
84. E.D. Rosen, C.J. Walkey, P. Puigserver, and B.M. Spiegelman, Transcriptional regulation of adipogenesis, Genes Dev. 14 (2000), pp. 1293-1307.
85. P. Tontonoz, E. Hu, R.A. Graves, A.I. Budavari, and B.M. Spiegelman, mPPAR γ 2: Tissue-specific regulator of an adipocyte enhancer, Genes Dev. 8 (1994), pp. 1224-1234.
86. P. Tontonoz, J.B. Kim, R.A. Graves, and B.M. Spiegelman, ADD1: A novel helixloop-helix transcription factor associated with adipocyte determination and differentiation, Mol. Cell. Biol. 13 (1993), pp. 4753-4759.
87. T. Imai, R. Takakuwa, S. Marchand, E. Dentz, J.M. Bornert, N. Messaddeq, O. Wendling, M. Mark, B. Desvergne, W. Wahli, P. Chambon, and D. Metzger, Peroxisome proliferator-activated receptor γ is required in mature white and brown adipocytes for their survival in the mouse, Proc. Natl. Acad. Sci. USA 101 (2004), pp. 4543-4547.
88. N. Kubota, Y. Terauchi, H. Miki, H. Tamemoto, T. Yamauchi, K. Komeda, S. Satoh, R. Nakano, C. Ishii, T. Sugiyama, K. Eto, Y. Tsubamoto, A. Okuno, K. Murakami, H. Sekihara, G. Hasegawa, M. Naito, Y. Toyoshima, S. Tanaka, K. Shiota, T. Kitamura, T. Fujita, O. Ezaki, S. Aizana, R. Nagai, K. Tobe, S. Kimura, and T. Kadowaki, PPAR γ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance, Mol. Cell 4 (1999), pp. 597-609.
89. J. Rieusset, F. Touri, L. Michalik, P. Escher, B. Desvergne, E. Niesor, and W. Wahli, A new selective peroxisome proliferator-activated receptor γantagonist with antiobesity and antidiabetic activity, Mol. Endocrinol. 16 (2002), pp. 2628-2644.
90. E.D. Rosen, P. Sarraf, A.E. Troy, G. Bradwin, K. Moore, D.S. Milstone, B.M. Spiegelman, and R.M. Mortensen, PPAR γ is required for the differentiation of adipose tissue in vivo and in vitro, Mol. Cell 4 (1999), pp. 611-617.
91. B.D. Savage, G.D. Tan, C.L. Acerini, S.A. Jebb, M. Agostini, M. Gurnell, R.L. Williams, A.M. Umpleby, E.L. Thomas, J.D. Bell, A.K. Dixon, F. Dunne, R. Boiani, S. Cinti, A. Vidal-Ruig, F. Karpe, V.K.K. Chatterjee, and S. O’Rahilly, Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor γ, Diabetes 52 (2003), pp. 910-917.
92. Z. Wu, E.D. Rosen, R. Brun, S. Hauser, G. Adelmant, A.E. Troy, C. McKeon, G.J. Darlington, and B.M. Spiegelman, Cross-regulation of C/EBP α and PPAR γcontrols the transcriptional pathway of adipogenesis and insulin sensitivity, Mol. Cell 3 (1999), pp. 151-158.
93. I. Issemann and S. Green, Activation of a member of the steroid-hormone receptor superfamily by peroxisome proliferators, Nature 347 (1990), pp. 645-650.
94. D.Y. Lai, Rodent carcinogenicity of peroxisome proliferators and issues on human relevance, J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 22 (2004), pp. 37-55.
95. J.N. Feige, L. Gelman, D. Rossi, V. Zoete, R. Métivier, C. Tudor, S.I. Anghel, A. Grosdidier, C. Lathion, Y. Engelborghs, O. Michielin, W. Wahli, and B. Desvergne, The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor g modulator that promotes adipogenosis, J. Biol. Chem. 282 (2007), pp. 19152-19166.
96. C. Bettin, J. Oehlmann, and E. Stroben, TBT-induced imposex in marine neogasteropods in mediated by an increasing androgen level, Helgolander Meeresuntersuchungen 50 (1996), pp. 299-317.
97. T. Nakanishi, Potential toxicity of organotin compounds via nuclear receptor signaling in mammals, J. Health Sci. 53 (2007), pp. 1-9.
98. N. Spooner, P.E. Gibbs, G.W. Bryan, and L.J. Goad, The effects of tributyltin upon steroid titers in the female dogwhelk, Nucella lapillus, and the development of imposex, Mar. Environ. Res. 32 (1991), pp. 37-49.
99. J. Sonoda and R.M. Evans, Biological function and mode of action of nuclear xenobiotic receptors, Pure Appl. Chem. 75 (2003), pp. 1733-1742.
100. F. Oesch and M. Arand, Xenobiotic metabolism, in Toxicology, H. Marquardt, S.G. Schafer, R. McClellan, and F. Welsch, eds., Academic Press, New York, 1999, pp. 83-109.
101. W. Xie, M.F. Yeuh, A. Radominska-Pandya, S.P. Saini, Y. Negishi, B.S. Bottroff, G.Y. Cabrera, R.H. Tukey, and R.M. Evans, Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor, Proc. Natl. Acad. Sci. USA 100 (2003), pp. 4150-4155.
102. C.D. Klaassen and A.M. Hood, Effects of microsomal enzyme inducers on thyroid follicular cell proliferation and thyroid hormone metabolism, Toxicol. Pathol. 29 (2001), pp. 34-40.
103. S. Safe, Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds, Pharmacol. Ther. 67 (1995), pp. 247-281.
104. O. Hankinson, The aryl hydrocarbon receptor complex, Annu. Rev. Pharmacol. Toxicol. 35 (1995), pp. 307-340.
105. A.B. Okey, An aryl hydrocarbon receptor odyssey to the shores of toxicology: The Deichmann lecture, international congress of toxicology-XI, Toxicol. Sci. 98 (2007), pp. 5-38.
106. R. Barouki, X. Coumoul, and P. M. Fernandez-Salguero, The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein, FEBS Lett. 581 (2007), pp. 3608-3615.
107. F. Ohtake, K.I. Takeyama, T. Matsumoto, H. Kitagawa, Y. Yamamoto, K. Nohara, C. Tohyama, A. Krust, J. Mimura, P. Chambon, J. Yanagisawa, Y. Fujii-Kuriyama, and S. Kato, Modulation of oestrogen receptor signaling by association with activated dioxin receptor, Nature 423 (2003), pp. 545-550.
108. S. Safe and M. Wormke, Inhibitory aryl hydrocarbon receptor-estrogen receptor alpha cross-talk and mechanisms of action, Chem. Res. Toxicol. 16 (2003), pp. 807-826.
109. J. Matthews and J.A. Gustafsson, Estrogen receptor and aryl hydrocarbon receptor signaling pathways, Nucl. Recept. Signal. 4 (2006), p. e016.
110. J. Matthews, B. Wihlen, J. Thomsem, and J.A. Gustafsson, Aryl hydrocarbon receptor-mediated transcription: Ligand-dependant recruitment of estrogen receptor a to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters, Mol. Cell. Biol. 25 (2005), pp. 5517-5328.
111. J.T. Sanderson, The steroid hormone biosynthesis pathway as a target for endocrinedisrupting chemicals, Toxicol. Sci. 94 (2006), pp. 3-21.
112. W.L. Miller, Molecular biology of steroid-hormone synthesis, Endocrinol. Rev. 9 (1988), pp. 295-318.
113. J.F. Baroiller, Y. Guigen, and A. Fostier, Endocrine and environmental aspects of sex differentiation in fish, Cell. Mol. Life Sci. 55 (1999), pp. 910-931.
114. K. Cheshenko, F. Pakdel, H. Segner, O. Kah, and R.I.L. Eggen, Interference of endocrine disrupting chemicals with aromatase CYP19 expression or activity, and consequences for reproduction of teleost fish, Gen. Comp. Endocrinol. 155 (2008), pp. 31-62.
115. N. Aluru, R. Renaud, J.F. Leatherland, and M.M. Vijayan, Ah receptor-mediated impairment of interrenal steroidogenesis involves StAR protein and P450scc gene attenuation in rainbow trout, Toxicol. Sci. 84 (2005), pp. 260-269.
116. H.R. Andersen, A.M. Vinggaard, T.H. Rasmussen, I.M. Gjermandsen, and E.C. Bonefeld-Jorgensen, Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro, Toxicol. Appl. Pharmacol. 179 (2002), pp. 1-12.
117. S.A. Andric, T.S. Kostic, S.M. Dragisic, N.L. Andric, S.S. Stojilkovic, and R.Z. Kovacevic, Acute effects of polychlorinated biphenyl-containing and-free transformer fluids on rat testicular steroidogenesis, Environ. Health Perspect. 108 (2000), pp. 955-959.
118. P.J. Chedrese, M.R. Rodway, C.L. Swan, and C. Gillio-Meina, Establishment of a stable steroidogenic porcine granulosa cell line, J. Mol. Endoc. 20 (1998), pp. 287-292.
119. P.K. Ghosh, N.M. Biswas, and D. Ghosh, Effect of lithium-chloride on spermatogenesis and testicular steroidogenesis in mature albino-rats — Duration dependent response, Life Sci. 48 (1991), pp. 649-657.
120. P.M. Gocze, I. Szabo, Z. Porpaczy, and D.A. Freeman, Barbiturates inhibit progesterone synthesis in cultured Leydig tumor cells and human granulosa cells, Gynecol. End. 13 (1999), pp. 305-310.
121. B.M. Huang, H.Y. Lai, and M.Y. Liu, Concentration dependency in lead-inhibited steroidogenesis in MA-10 mouse Leydig tumor cells, J. Toxicol. Environ. Health Part A 65 (2002), pp. 557-567.
122. P.B. Kan, M.A. Hirst, and D. Feldman, Inhibition of steroidogenic cytochrome-P-450 enzymes in rat testis by ketoconazole and related imidazole antifungal drugs, J. Steroid Biochem. Mol. Biol. 23 (1985), pp. 1023-1029.
123. M. Kawai, K.F. Swan, A.E. Green, D.E. Edwards, M.B. Anderson, and M.C. Henson, Placental endocrine disruption induced by cadmium: Effects on P450 cholesterol side-chain cleavage and 3 β-hydroxysteroid dehydrogenase enzymes in cultured human trophoblasts, Biol. Reprod. 67 (2002), pp. 178-183.
124. W.R. Kelce, E. Monosson, M.P. Gamcsik, S.C. Laws, and L.E. Gray, Environmental hormone disruptors — Evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites, Toxicol. Appl. Pharmacol. 126 (1994), pp. 276-285.
125. M.J. McVey and G.M. Cooke, Inhibition of rat testis microsomal 3 β-hydroxysteroid dehydrogenase activity by tributyltin, J. Steroid Biochem. Mol. Biol. 86 (2003), pp. 99-105.
126. T. Nakanishi, J. Kohroki, S. Suzuki, J. Ishizaki, Y. Hiromori, S. Takasuga, N. Itoh, Y. Watanabe, N. Utoguchi, and K. Tanaka, Trialkyltin compounds enhance human CG secretion and aromatase activity in human placental choriocarcinoma cells, J. Clin. Endocrinol. Metab. 87 (2002), pp. 2830-2837.
127. H. Nikula, T. Talonpoika, M. Kaleva, and J. Toppari, Inhibition of hCG-stimulated steroidogenesis in cultured mouse Leydig tumor cells by bisphenol A and octylphenols, Toxicol. Appl. Pharmacol. 157 (1999), pp. 166-173.
128. S. Ohno, S. Shinoda, S. Toyoshima, H. Nakazawa, T. Makino, and S. Nakajin, Effects of flavonoid phytochemicals on cortisol production and on activities of steroidogenic enzymes in human adrenocortical H295R cells, J. Steroid Biochem. Mol. Biol. 80 (2002), pp. 355-363.
129. B.L. Roman, R.J. Sommer, K. Shinomiya, and R.E. Peterson, In utero and lactational exposure of the male-rat to 2,3,7,8-Tetrachlorodibenzo-p-dioxin — Impaired prostate growth and development without inhibited androgen production, Toxicol. Appl. Pharmacol. 134 (1995), pp. 241-250.
130. A.M. Ronco, K. Valdes, D. Marcus, and M. Llanos, The mechanism for lindaneinduced inhibition of steroidogenesis in cultured rat Leydig cells, Toxicology 159 (2001), pp. 99-106.
131. M. Saitoh, T. Yanase, H. Morinaga, M. Tanabe, Y.M. Mu, Y. Nishi, M. Nomura, T. Okabe, K. Goto, R. Takayanagi, and H. Nawata, Tributyltin or triphenyltin inhibits aromatase activity in the human granulosa-like tumor cell line KGN, Biochem. Biophys. Res. Commun. 289 (2001), pp. 198-204.
132. J.T. Sanderson, J. Boerma, G.W.A. Lansbergen, and M. van den Berg, Induction and inhibition of aromatase (CYP19) activity by various classes of pesticides in H295R human adrenocortical carcinoma cells, Toxicol. Appl. Pharmacol. 182 (2002), pp. 44-54.
133. J.T. Sanderson, W. Seinen, J.P. Giesy, and M. van den Berg, 2-chloro-s-triazine herbicides induce aromatase (CYP19) activity in H295R human adrenocortical carcinoma cells: A novel mechanism for estrogenicity? Toxicol. Sci. 54 (2000), pp. 121-127.
134. R. Thibaut and C. Porte, Effects of endocrine disrupters on sex steroid synthesis and metabolism pathways in fish, J. Steroid Biochem. Mol. Biol. 92 (2004), pp. 485-494.
135. A.M. Vinggaard, C. Hnida, V. Breinholt, and J.C. Larsen, Screening of selected pesticides for inhibition of CYP19 aromatase activity in vitro, Toxicol. In Vitro 14 (2000), pp. 227-234.
136. L.P. Walsh, C. McCormick, C. Martin, and D.M. Stocco, Roundup inhibits steroidogenesis by disrupting steroidogenic acute regulatory (StAR) protein expression, Environ. Health Perspect. 108 (2000), pp. 769-776.
137. L.P. Walsh and D.M. Stocco, Effects of lindane on steroidogenesis and steroidogenic acute regulatory protein expression, Biol. Reprod. 63 (2000), pp. 1024-1033.
138. H. Morinaga, T. Yanase, M. Nomura, T. Okabe, K. Goto, N. Harada, and H. Nawata, A benzimidazole fungicide, benomyl, and its metabolite, carbendazim, induce aromatase activity in a human ovarian granulose-like tumor cell line (KGN), Endocrinology 145 (2004), pp. 1860-1869.
139. G.G. Gibson, N.J. Plant, K.E. Swales, A. Ayrton, and W. El-Sankary, Receptordependent transcriptional activation of cytochrome P450A genes: Induction mechanisms, species differences, and interindividual variation in man, Xenobiotica 32 (2002), pp. 165-206.
140. S.W. Chen, P.J. Dziuk, and B.M. Francis, Effect of four environmental toxicants on plasma Ca and estradiol 17β and hepatic P450 in laying hens, Environ. Toxicol. Chem. 13 (1994), pp. 789-796.
141. S.W. Chen, B.M. Francis, and P.J. Dziuk, Effect of concentration of mixed-function oxidase on concentration of estrogen, rate of egg lay, eggshell thickness, and plasma calcium in laying hens, J. Anim. Sci. 71 (1993), pp. 2700-2707.
142. A. Bammel, K. Vandermee, E.E. Ohnhaus and W. Kirch, Divergent effects of different enzyme-inducing agents on endogenous and exogenous testosterone, Eur. J. Clin. Pharmacol. 42 (1992), pp. 641-644.
143. B. Blumberg, W. Sabbagh, H. Juguilon, J. Bolado, C.M. Van Meter, E.S. Ong, and R.M. Evans, SXR, a novel steroid and xenobiotic-sensing nuclear receptor, Genes Dev. 12 (1998), pp. 3195-3205.
144. W. Xie, J.L. Barwick, M. Downes, B. Blumberg, C.M. Simon, M.C. Nelson, B.A. Neuschwander-Tetri, E.M. Bruntk, P.S. Guzelian, and R.M. Evans, Humanized xenobiotic response in mice expressing nuclear receptor SXR, Nature 206 (2000), pp. 435-439.
145. J.A. Gustafsson, Regulation of sexual dimorphism in rat liver, in The Differences between Sexes, R.V. Short and E. Balaban, eds., Cambridge University Press, Cambridge, 1994, pp. 231-241.
146. M.P. Gunderson, G.A. LeBlanc, and L.J. Guillette, Alterations in sexually dimorphic biotransformation of testosterone in juvenile American alligators (Alligator mississippiensis) from contaminated lakes, Environ. Health Perspect. 109 (2001), pp. 1257-1264.
147. M.P. Gunderson, E. Oberdorster, and L.J. Guillette, Phase I and II enzyme activities in juvenile alligators (Alligator mississipiensis) collected from three sites in the Kissimmee-Everglades drainage, Florida (USA), Comp. Biochem. Physiol. C Toxicol. Pharmacol. 139 (2004), pp. 39-46.
148. L.J. Guillette, Endocrine disrupting contaminants — Beyond the dogma, Environ. Health Perspect. 114 (2006), pp. 9-12.
149. V.S. Wilson and G.A. LeBlanc, Endosulfan elevates testosterone biotransformation and clearence in CD-1 mice, Toxicol. Appl. Pharmacol. 148 (1998), pp. 158-168.
150. V.S. Wilson and G.A. Leblanc, The contribution of hepatic inactivation of testosterone to the lowering of serum testosterone levels by ketoconazole, Toxicol. Sci. 54 (2000), pp. 128-137.
151. M.M. Tabb and B. Blumberg, New modes of action for endocrine-disrupting chemicals, Mol. Endocrinol. 20 (2006), pp. 475-482.
152. H. Syvala, A. Vienonen, Y.H. Zhuang, M. Kivineva, T. Ylikomi, and P. Tuohimaa, Evidence for enhanced ubiquitin-mediated proteolysis of the chicken progesterone receptor by progesterone, Life Sci. 63 (1998), pp. 1505-1512.
153. H.K. Lin, S. Altuwaijri, W.J. Lin, P.Y. Kan, L.L. Collins, and C. Chang, Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells, J. Biol. Chem. 277 (2002), pp. 36570-36576.
154. L. Sheflin, B. Keegan, W. Zhang, and S.W. Spaulding, Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous endocrine receptor levels, Biochem. Biophys. Res. Commun. 276 (2000), pp. 144-150.
155. A.L. Wijayaratne and D.P. McDonnell, The human estrogen receptor-α is an ubiquinated protein whose stability is affected differentially by agonists, antagonists and selective estrogen receptor modulator, J. Biol. Chem. 276 (2001), pp. 35684-35692.
156. U. Westphal, Sex steroid-binding protein (SBP), in Steroid-Protein Interactions II. Monographs on Endocrinology, Springer-Verlag, New York, 1986, pp. 198-264.
157. N. Fortunati, Sex hormone-binding globulin: Not only a transport protein. What news is around the corner? J. Endoc. Inv. 22 (1999), pp. 223-234.
158. H. Déchaud, C. Ravard, F. Claustrat, A. Brac de la Perrière, and M. Pugeat, Xenoestrogen interaction with human sex hormone-binding globulin (hSHBG), Steroids 64 (1999), pp. 328-334.
159. M.E. Martin, M. Haourigui, C. Pelissero, C. Benassayag, and E.A. Nunez, Interactions between phytoestrogens and human sex steroid binding protein, Life Sci. 58 (1996), pp. 429-436.
160. S.R. Milligan, O. Khan, and M. Nash, Competitive binding of xenobiotic oestrogens to rat alpha-fetoprotein and to sex steroid-binding proteins in human and rainbow trout (Oncorhyncus mykiss) plasma, Gen. Comp. Endocrinol. 112 (1998), pp. 89-95.
161. K.E. Tollefsen, Interaction of estrogen mimics, singly and in combination, with plasma sex steroid-binding proteins in rainbow trout (Oncorhynchus mykiss), Aquat. Toxicol. 56 (2002), pp. 215-225.
162. K.E. Tollefsen, J. Ovrevik, and J. Stenersen, Binding of xenoestrogens to the sex steroid-binding protein in plasma from Arctic chaff (Salvelinus alpinus L.), Comp. Biochem. Physiol. C Toxicol. Pharmacol. 139 (2004), pp. 127-133.
163. S.F. Arnold, B.M. Collins, M.K. Robinson, L.J. Guillette, and J.A. McLachlan, Differential interaction of natural and synthetic estrogens with extracellular binding proteins in yeast estrogen screen, Steroids 61 (1996), pp. 642-646.
164. D.A. Crain, N. Noriega, P.M. Vonier, S.F. Arnold, J.A. McLachlan, and L.J. Guillette, Cellular bioavailability of natural hormones and environmental contaminants as a function of serum and cytosolic binding factors, Toxicol. Ind. Health 14 (1998), pp. 261-273.
165. S.C. Nagel, F.S. vom Saal, and W.V. Welshons, The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: Physiology of delivery modifies estrogenic activity, Proc. Soc. Exp. Biol. Med. 217 (1998), pp. 300-309.
166. M.D. Anway, A.S. Cupp, M. Uzumcu, and M.K. Skinner, Epigenetic transgenerational actions of endocrine disruptors and male fertility, Science 308 (2005), pp. 1466-1469.
167. P.M.D. Foster, Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters, Int. J. Androl. 29 (2006), pp. 140-147.
168. S.M. Ho, W.Y. Tang, J. Belmonte de Frausto, and G.S. Prins, Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4, Cancer Res. 66 (2006), pp. 5624-5632.
169. R.R. Newbold, E. Padilla-Banks, and W.N. Jefferson, Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations, Endocrinology 147 (2006), pp. S11-S17.
170. W.Y. Tang and S.M. Ho, Epigenetic reprogramming and imprinting in origins of disease, Rev. Endocr. Metab. Disord. 8 (2007), pp. 173-182.
171. R. Jaenisch and A. Bird, Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals, Nat. Genet. 33 (2003), pp. 245-254.
172. L. Van Speybroeck, From epigenesis to epigenetics: The case of W. H. Waddington, Ann. N.Y. Acad. Sci. 981 (2002), pp. 61-81.
173. A. Akhtar and G. Cavalli, The epigenome network of excellence, PLoS Biol. 3 (2005), pp. e177.
174. P.A. Jones and D. Takai, The role of DNA methylation in mammalian epigenetics, Science 293 (2001), pp. 1068-1070.
175. R. Holliday, DNA methylation and epigenetic mechanisms, Cell Biophys. 15 (1989), pp. 15-20.
176. E. Li, T.H. Bestor, and R. Jaenisch, Targeted mutation of the DNA methyl-transferase gene results in embryonic lethality, Cell 69 (1992), pp. 915-926.
177. A.L. Herbst, H. Ulfelder, and D.C. Poskanzer, Adenocarcinoma of the vagina association of the maternal stilbestrol therapy, with tumor appearance in young women, New Engl. J. Med. 284 (1971), pp. 878-881.
178. J. McLachlan, R. Newbold, and B. Bullock, Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol, Cancer Res. 40 (1980), pp. 3988-3999.
179. R.R. Newbold, R.B. Hanson, W.N. Jefferson, B.C. Bullock, J. Haseman, and J.A. McLachlan, Increased tumors but uncompromised fertility in the female descendants mice exposed developmentally to diethylstilbestrol, Carcinogenesis 19 (1998), pp. 1655-1663.
180. R.R. Newbold, R.B. Hanson, W.N. Jefferson, B.C. Bullock, J. Haseman, and J.A. McLachlan, Proliferative lesions and reproductive tract tumors in male descendants of mice exposed developmentally to diethylstilbestrol, Carcinogenesis 21 (2000), pp. 1355-1363.
181. D. Crews and J.A. McLachlan, Epigenetics, evolution, endocrine disruption, health, and disease, Endocrinology 147 (2006), pp. S4-S10.
182. Q. Wu, S. Ohsako, R. Ishimura, J.S. Suzuki, and C. Tohyama, Exposure of mouse preimplantation embryos to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters the methylation status of imprinted genes H19 and Igf2, Biol. Reprod. 70 (2004), pp. 1790-1797.
183. D. Desaulniers, G.H. Xiao, K. Leingartner, I. Chu, B. Musicki, and B.K. Tsang, Comparisons of brain, uterus, and liver mRNA expression for cytochrome P450s, DNA methyltransferase-1, and cathecol-o-methyltransferase in prepurbertal female Sprague-Dawley rats exposed to a mixture of aryl hydrocarbon receptor agonists, Toxicol. Sci. 86 (2005), pp. 175-184.
184. J.A. McLachlan, E. Simpson, and M. Martin, Endocrine disrupters and female reproductive health, Best Pract. Res. Clin. Endocrinol. Metab. 20 (2006), pp. 63-75.
185. L. Tao, W. Wang, L. Li, P.K. Kramer, and M.A. Pereira, DNA hypomethylation induced by drinking water disinfection by-products in mouse and rat kidney, Toxicol. Sci. 87 (2005), pp. 344-352.
186. M. Fu, C. Wang, J. Wang, X. Zhang, T. Sakamaki, Y.G. Yeung, C. Chang, T. Hopp, S.A.W. Fuqua, E. Jaffray, R.T. Hay, J.J. Palvimo, O.A. Jänne, and R.G. Pestell, Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function, Mol. Cell. Biol. 22 (2002), pp. 3373-3388.
187. A. Kortenkamp, Ten years of mixing cocktails: A review of combination effects of endocrine-disrupting chemicals, Environ. Health Perspect. 115 Suppl 1 (2007), pp. 98-105.
188. A. Kortenkamp and R. Altenburger, Synergisms with mixtures of xenoestrogens: A reevaluation using the method of isoboles, Sci. Total Environ. 221 (1998), pp. 59-73.
189. J.V. Brian, C.A. Harris, M. Scholze, T. Backhaus, P. Booy, M. Lamoree, G. Pojana, N. Jonkers, T. Runnalls, A. Bonfa, A. Marcomini, and J.P. Sumpter, Accurate prediction of the response of freshwater fish to a mixture of estrogenic chemicals, Environ. Health Perspect. 113 (2005), pp. 721-728.
190. G.D. Charles, C. Genning, T. Zacharewski, B.B. Gollapudi, and E.W. Carney, Assessment of interactions of diverse ternary mixtures in an estrogen receptor-a reporter assay, Toxicol. Appl. Pharmacol. 180 (2002), pp. 11-21.
191. K.M. Crofton, E.S. Craft, J.M. Hedge, C. Gennings, J.E. Simmons, R.A. Carchman, W.H. Carter, and M.J. DeVito, Thyroid-hormone-disrupting chemicals: Evidence for dosedependent additivity or synergism, Environ. Health Perspect. 113 (2005), pp. 1549-1554.
192. Y. Le Page, M. Scholze, O. Kah, and F. Pakdell, Assessment of xenoestrogens using three distinct estrogen receptors and the zebrafish brain aromatase gene in a highly responsive glial cell system, Environ. Health Perspect. 114 (2006), pp. 752-758.
193. K.L. Thorpe, R.I. Cummings, T.H. Hutchinson, M. Scholze, G. Brighty, J.P. Sumpter, and C.R. Tyler, Relative potencies and combination effects of steroidal estrogens in fish, Environ. Sci. Technol. 37 (2003), pp. 1142-1149.
194. H. Tinwell and J. Ashby, Sensitivity of the immature rat uterotrophic assay to mixtures of estrogens, Environ. Health Perspect. 112 (2004), pp. 575-582.
195. W.V. Welshons, K.A. Thayer, B.M. Judy, J.A. Taylor, E.M. Curran, and F.S. vom Saal, Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity, Environ. Health Perspect. 111 (2003), pp. 994-1006.
196. D.M. Sheehan, No-threshold dose-response curves for nongenotoxic chemicals: Findings and applications for risk assessment, Environ. Res. 100 (2006), pp. 93-99.
197. A.C. Gore, J.J. Heindel, and R.T. Zoeller, Endocrine disruption for endocrinologists (and others), Endocrinology 147 (2006), pp. S1-S3.
198. H.A. Bern, K.T. Mills, D. Hatch, P.L. Ostrander, and T. Iguchi, Altered mammary responsiveness to estradiol and progesterone in mice exposed neonatally to diethylstilbestrol, Cancer Lett. 63 (1992), pp. 117-124.
199. T. Colborn and C. Clement, Chemically induced alterations in sexual and functional development: The wildlife/human connection, Princeton Scientific, Princeton, NJ, 1992.
200. M.S. Golub, C.E. Hogrefe, S.L. Germann, and C.P. Jerome, Endocrine disruption in adolescence: Immunologic, hematologic, and bone effects in monkeys, Toxicol. Sci. 82 (2004), pp. 598-607.
201. M.D. Anway and M.K. Skinner, Epigenetic transgenerational actions of endocrine disruptors, Endocrinology 147 (2006), pp. S43-S49.
202. J.J. Heindel, Endocrine disruptors and the obesity epidemic, Toxicol. Sci. 76 (2003), pp. 247-249.
203. R.R. Newbold, E. Padilla-Banks, R.J. Snyder, T.M. Phillips, and W.N. Jefferson, Developmental exposure to endocrine disruptors and the obesity epidemic, Reprod. Toxicol. 23 (2007), pp. 290-296.
204. S.E. Fenton, Endocrine-disrupting compounds and mammary gland development: Early exposure and later life consequences, Endocrinology 147 (2006), pp. S18-S24.
205. H. Kojima, E. Katsura, S. Takeuchi, K. Niiyama, and F. Kobayashi, Screening for estrogen and androgen receptor activities in 200 pesticides by in vitro reporter gene assays using chinese hamster ovary cells, Environ. Health Perspect. 112 (2004), pp. 524-531.
206. R. McKinlay, J.A. Plant, J.N.B. Bell, and N. Voulvoulis, Endocrine disrupting pesticides: Implications for risk assessment, Environ. Int. 34 (2008), pp. 168-183.
207. P.J. Chedrese, M.R. Rodway, C.L. Swan, and C. Gillio-Meina, Establishment of a stable steroidogenic porcine granulosa cell line, J. Mol. Endocrinol. 20 (1998), pp. 287-292.